Quest Diagnostics Inc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Quest Diagnostics Inc (DGX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $39.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-07-23
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $39.00M, a 11.36% decline year-over-year.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $62.00M, a 19.23% increase year-over-year.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $59.00M, a 73.53% increase year-over-year.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $44.00M, a 33.33% increase year-over-year.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $199.00M, a 29.22% increase from fiscal 2024.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $154.00M, a 14.92% decline from fiscal 2023.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $181.00M, a 17.53% increase from fiscal 2022.
- Quest Diagnostics Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $154.00M, a 2.67% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.00M 10-Q · filed 2026-07-23 | $101.00M 10-Q · filed 2026-07-23 | $160.00M derived: sum of 3 quarters · filed 2026-07-23 | $204.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $62.00M 10-Q · filed 2026-04-22 | $121.00M derived: sum of 2 quarters · filed 2026-04-22 | $165.00M derived: sum of 3 quarters · filed 2026-04-22 | $209.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $59.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $103.00M derived: sum of 2 quarters · filed 2026-02-26 | $147.00M derived: sum of 3 quarters · filed 2026-07-23 | $199.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $44.00M 10-Q · filed 2025-10-21 | $88.00M derived: sum of 2 quarters · filed 2026-07-23 | $140.00M 10-Q · filed 2025-10-21 | $174.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $44.00M 10-Q · filed 2026-07-23 | $96.00M 10-Q · filed 2026-07-23 | $130.00M derived: sum of 3 quarters · filed 2026-07-23 | $163.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $52.00M 10-Q · filed 2026-04-22 | $86.00M derived: sum of 2 quarters · filed 2026-04-22 | $119.00M derived: sum of 3 quarters · filed 2026-04-22 | $171.00M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $67.00M derived: sum of 2 quarters · filed 2026-02-26 | $119.00M derived: sum of 3 quarters · filed 2026-02-26 | $154.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | $33.00M 10-Q · filed 2025-10-21 | $85.00M derived: sum of 2 quarters · filed 2025-10-21 | $120.00M 10-Q · filed 2025-10-21 | $158.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $52.00M 10-Q · filed 2025-07-23 | $87.00M 10-Q · filed 2025-07-23 | $125.00M derived: sum of 3 quarters · filed 2026-02-26 | $167.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $35.00M 10-Q · filed 2025-04-23 | $73.00M derived: sum of 2 quarters · filed 2026-02-26 | $115.00M derived: sum of 3 quarters · filed 2026-02-26 | $172.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $80.00M derived: sum of 2 quarters · filed 2026-02-26 | $137.00M derived: sum of 3 quarters · filed 2026-02-26 | $181.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $42.00M 10-Q · filed 2024-10-23 | $99.00M derived: sum of 2 quarters · filed 2024-10-23 | $143.00M 10-Q · filed 2024-10-23 | $164.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $57.00M 10-Q · filed 2024-07-24 | $101.00M 10-Q · filed 2024-07-24 | $122.00M derived: sum of 3 quarters · filed 2025-02-20 | $171.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $44.00M 10-Q · filed 2024-04-24 | $65.00M derived: sum of 2 quarters · filed 2025-02-20 | $114.00M derived: sum of 3 quarters · filed 2025-02-20 | $135.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $70.00M derived: sum of 2 quarters · filed 2025-02-20 | $91.00M derived: sum of 3 quarters · filed 2025-02-20 | $154.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $49.00M 10-Q · filed 2023-10-25 | $70.00M derived: sum of 2 quarters · filed 2023-10-25 | $133.00M 10-Q · filed 2023-10-25 | $168.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $21.00M 10-Q · filed 2023-07-27 | $84.00M 10-Q · filed 2023-07-27 | $119.00M derived: sum of 3 quarters · filed 2024-02-22 | $165.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $63.00M 10-Q · filed 2023-04-28 | $98.00M derived: sum of 2 quarters · filed 2024-02-22 | $144.00M derived: sum of 3 quarters · filed 2024-02-22 | $177.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $35.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $81.00M derived: sum of 2 quarters · filed 2024-02-22 | $114.00M derived: sum of 3 quarters · filed 2024-02-22 | $150.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | $46.00M 10-Q · filed 2022-10-21 | $79.00M derived: sum of 2 quarters · filed 2022-10-21 | $115.00M 10-Q · filed 2022-10-21 | $215.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $33.00M 10-Q · filed 2022-07-22 | $69.00M 10-Q · filed 2022-07-22 | $169.00M derived: sum of 3 quarters · filed 2023-02-21 | $209.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $36.00M 10-Q · filed 2022-04-22 | $136.00M derived: sum of 2 quarters · filed 2023-02-21 | $176.00M derived: sum of 3 quarters · filed 2023-02-21 | $223.00M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $140.00M derived: sum of 2 quarters · filed 2023-02-21 | $187.00M derived: sum of 3 quarters · filed 2023-02-21 | $219.00M 10-K · filed 2023-02-21 |
| 2020-09-30 | $40.00M 10-Q · filed 2021-10-22 | $87.00M derived: sum of 2 quarters · filed 2021-10-22 | $119.00M 10-Q · filed 2021-10-22 | $167.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $47.00M 10-Q · filed 2021-07-23 | $79.00M 10-Q · filed 2021-07-23 | $127.00M derived: sum of 3 quarters · filed 2022-02-28 | $165.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $32.00M 10-Q · filed 2021-04-23 | $80.00M derived: sum of 2 quarters · filed 2022-02-28 | $118.00M derived: sum of 3 quarters · filed 2022-02-28 | $171.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $48.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $86.00M derived: sum of 2 quarters · filed 2022-02-28 | $139.00M derived: sum of 3 quarters · filed 2022-02-28 | $164.00M 10-K · filed 2022-02-28 |
| 2019-09-30 | $38.00M 10-Q · filed 2020-10-23 | $91.00M derived: sum of 2 quarters · filed 2020-10-23 | $116.00M 10-Q · filed 2020-10-23 | |
| 2019-06-30 | $53.00M 10-Q · filed 2020-07-24 | $78.00M 10-Q · filed 2020-07-24 | ||
| 2019-03-31 | $25.00M 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |